What's New at BioGX Oct 21 BioGX Receives CE-IVD Mark For Enhanced Flu Assay Amsterdam, The Netherlands, 22 October 2019 - BioGX B.V., the European subsidiary of Birmingham, Alabama based BioGX, announced it has received CE-IVD marking for its new Flu A, Flu... Nov 1 BioGX Celebrates Success of Global Partnership Initiative, Announces New Distribution Partnerships in EMEA and Asia-Pacific Amsterdam, The Netherlands, 01 November 2018 – Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, today announced several new... Oct 24 BioGX Launches 5 new CE Mark IVD Tests, Expands Number of Sexual Health Panels Amsterdam, The Netherlands, 23 October 2018 – BioGX B.V. recently released 5 new sexual health CE Mark IVD tests, expanding BioGX’s CE-IVD menu to a total of 21 multiplex panels, with... May 24 BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance Amsterdam, The Netherlands, 24 May 2018 – BioGX B.V. continues its *BD MAX menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and... There is currently no news to display
